Nicotinamide for skin cancer chemoprevention in transplant recipients: a critically appraised topic
- PMID: 37665964
- DOI: 10.1093/bjd/ljad318
Nicotinamide for skin cancer chemoprevention in transplant recipients: a critically appraised topic
Conflict of interest statement
Conflicts of interest: A.J.-P. has previously served as an advisor for Regeneron.
Comment on
-
Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.N Engl J Med. 2023 Mar 2;388(9):804-812. doi: 10.1056/NEJMoa2203086. N Engl J Med. 2023. PMID: 36856616 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical